Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found

详细信息    查看全文

• 作者：Eirini I. Rigopoulou^a ; ^{eirigopoulou@med.uth.gr} ; Dirk Roggenbuck^b ; ^c ; ^{dirk.roggenbuck@hs-lausitz.de} ; Daniel S. Smyk^d ; ^{daniel.s.smyk@gmail.com} ; Christos Liaskos^d ; ^e ; ^{liaskosch@med.uth.gr} ; Maria G. Mytilinaiou^d ; ^e ; ^{maria.mytilinaiou@kcl.ac.uk} ; Eugen Feist^f ; ^{eugen.feist@charite.de} ; Karsten Conrad^g ; ¹ ; ^{k_conrad@mail.zih.tu-dresden.de} ; Dimitrios P. Bogdanos^a ; ^d ; ^e ; ¹ ; ^{dimitrios.bogdanos@kcl.ac.uk} ;
• 关键词：ANA ; anti-nuclear antibody ; ASGPR ; asialoglycoprotein receptor ; AIH ; autoimmune hepatitis ; DIC ; disseminated intravascular coagulation ; EIA ; enzyme immunoassay ; ELISA ; enzyme-linked immunosorbent assay ; GlcNAc ; N-acetylglucosamine ; HAV ; hepatitis A virus
• 刊名：Autoimmunity Reviews
• 出版年：2012
• 出版时间：December, 2012
• 年：2012
• 卷：12
• 期：2
• 页码：260-269
• 全文大小：793 K

文摘

Asialoglycoprotein receptor (ASGPR) has attracted the attention of liver immunologists for many years. This liver-specific lectin was found to be a major B and T cell autoantigenic target in patients with autoimmune liver diseases, and in particular in autoimmune hepatitis (AIH). This review discusses the biological significance of ASGPR and its relevance to the pathogenesis of autoimmune and virus-triggered liver diseases. We also discuss emerging data on the diagnostic and clinical relevance of anti-ASGPR antibodies in light of recent reports based on commercially available anti-ASGPR enzyme-linked immunosorbent assays. Finally, we critically revisit the data reporting on disease-specific cellular immune responses against ASGPR and their relevance in relation to the pathogenesis of AIH.